How to bid on the Pharmacy Uniform Formulary for the Department of War

What the agency is buying

The Department of War, through the Defense Health Agency, is seeking pharmaceutical quotes for six newly approved drugs. These drugs will be considered for inclusion on the Department of War Uniform Formulary. The agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the decisions made regarding the formulary.

This opportunity is for pharmaceutical companies that can supply Furoscix ReadyFlow (Diuretics), Gwyn Lo (Contraceptive Agents), Jideytro (Lung Cancer), Omlyclo (Atopy), RizaFilm (Migraine Agents), and Zenbexus (Multiple Myeloma).

Key dates and deadlines

This Request for Quotation (RFQ) was published on September 3, 2026. A pre-quotation teleconference is scheduled for September 9, 2026. The final deadline for submitting your quotation is September 24, 2026, at 1:00 PM ET. All responses must be submitted by this time.

Responses to clinical questions, as detailed in Part 3.4 of the RFQ, must be submitted via email to the RFQ Point of Contact by the date specified in Part 2.3.2 of the document.

Who this opportunity suits

This opportunity is suitable for pharmaceutical manufacturers or distributors specializing in the drug categories listed: diuretics, contraceptive agents, lung cancer treatments, atopy treatments, migraine agents, and multiple myeloma treatments. Firms with established products that align with the newly approved drugs mentioned are encouraged to respond.

This is a healthcare-related procurement, specifically for the supply of pharmaceutical agents to the Military Health System.

How to respond

To access the full details of this opportunity, you will need to view the original source on the portal. Click the designated link to open the opportunity. If the first click takes you to the portal's homepage, click the link again to go directly to the bid.

You may need to create a free account on the portal to view all associated documents, though this is not always required for every bid. The RFQ document, HT9402-26-Q-9403, contains all instructions, important deadlines, and points of contact.

Tips for a competitive response

Carefully review the entire Request for Quotation, paying close attention to the specific requirements for both Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Ensure your quotation addresses all requested information for each drug.

Attend the pre-quotation teleconference on September 9, 2026, to clarify any questions you may have. This is an important opportunity to understand the agency's expectations directly. Submit any clinical questions via email by the specified deadline to ensure you receive official responses.

Clearly articulate the relative clinical effectiveness and relative cost effectiveness of your pharmaceutical agents, as these are key criteria for the Department of War Pharmacy and Therapeutics Committee. Provide all required documentation and pricing information accurately and completely.